company background image
OSUR logo

OraSure Technologies NasdaqGS:OSUR Stock Report

Last Price

US$6.14

Market Cap

US$453.1m

7D

-5.8%

1Y

5.1%

Updated

27 Mar, 2024

Data

Company Financials +

OraSure Technologies, Inc.

NasdaqGS:OSUR Stock Report

Market Cap: US$453.1m

OSUR Stock Overview

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally.

OSUR fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

OraSure Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OraSure Technologies
Historical stock prices
Current Share PriceUS$6.14
52 Week HighUS$8.45
52 Week LowUS$4.38
Beta0.17
1 Month Change-12.41%
3 Month Change-25.93%
1 Year Change5.14%
3 Year Change-47.39%
5 Year Change-42.99%
Change since IPO11.64%

Recent News & Updates

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01
Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Recent updates

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01
Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20
OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08
Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09
Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16
Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17
Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Jan 16
We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

OraSure wins $8.6M government contract for next-gen Ebola test

Sep 28

OraSure: Revenue Mix Continues To Present Risk

Sep 06

Biden administration ending free at-home COVID tests due to lack of funding

Aug 29

Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Aug 11
Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14
Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

Jun 10

OraSure Technologies: A Bet On What Used To Be

Mar 05

OraSure Technologies (NASDAQ:OSUR) May Have Issues Allocating Its Capital

Nov 11
OraSure Technologies (NASDAQ:OSUR) May Have Issues Allocating Its Capital

The Bottom Fishing Club: OraSure Technologies

Oct 22

Shareholder Returns

OSURUS Medical EquipmentUS Market
7D-5.8%2.2%0.4%
1Y5.1%13.3%28.8%

Return vs Industry: OSUR underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: OSUR underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is OSUR's price volatile compared to industry and market?
OSUR volatility
OSUR Average Weekly Movement6.1%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: OSUR's share price has been volatile over the past 3 months.

Volatility Over Time: OSUR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000638Carrie Eglinton Mannerhttps://www.orasure.com

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services.

OraSure Technologies, Inc. Fundamentals Summary

How do OraSure Technologies's earnings and revenue compare to its market cap?
OSUR fundamental statistics
Market capUS$453.11m
Earnings (TTM)US$53.66m
Revenue (TTM)US$405.47m

8.4x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OSUR income statement (TTM)
RevenueUS$405.47m
Cost of RevenueUS$226.05m
Gross ProfitUS$179.42m
Other ExpensesUS$125.77m
EarningsUS$53.66m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.73
Gross Margin44.25%
Net Profit Margin13.23%
Debt/Equity Ratio0%

How did OSUR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.